Detailed Overview and Clinical Management of Acute Bronchitis and Bronchiolitis for Pediatric Patient

A table summarizing the key differences, high-yield points, and management strategies for acute bronchitis and bronchiolitis, tailored for pediatric residency:

---

Acute Bronchitis:

Definition: Acute bronchitis is an inflammation of the bronchial tubes, usually following an upper respiratory tract infection (URTI). It predominantly affects the large airways (bronchi) and is characterized by cough and sputum production. While it can occur in all age groups, acute bronchitis is most commonly diagnosed in older children, adolescents, and adults.

Etiology:

• Viral Causes: The majority of acute bronchitis cases are viral in origin. Common viruses include:
  • Influenza A and B: Often seasonal and can cause more severe systemic symptoms.
  • Parainfluenza: Common in younger children, especially in late fall and early spring.
  • Coronavirus: Includes common cold coronaviruses and more severe forms like SARS-CoV-2.
  • Rhinovirus: One of the most common causes of URTIs and acute bronchitis.
  • Respiratory Syncytial Virus (RSV): Particularly prevalent in children under 2 years, though it can cause acute bronchitis in older children and adults.
  • Adenovirus: Known for prolonged symptoms and can also cause pharyngitis, conjunctivitis, and diarrhea.
• Bacterial Causes (Less Common):
  • Mycoplasma pneumoniae: Often affects school-aged children and adolescents; presents with a dry cough and can be associated with extrapulmonary manifestations.
  • Chlamydia pneumoniae: Typically mild but may contribute to chronic cough.
  • Bordetella pertussis: Causes pertussis (whooping cough), which can present as acute bronchitis in the early stages or in vaccinated individuals.
• Non-Infectious Causes:
  • Environmental irritants: Such as tobacco smoke, air pollution, and chemical fumes, which can cause or exacerbate symptoms.

Pathophysiology: Infection or irritation leads to inflammation of the bronchial mucosa, causing hyperemia, edema, and increased mucus production. This results in narrowed airways and cough, which is the body’s mechanism to clear mucus. Inflammation can also cause epithelial damage, which contributes to cough and mucus hypersecretion.

Clinical Presentation:

• Symptoms:
  • Cough: The hallmark symptom, which can be productive or non-productive. Typically starts acutely and can persist for 1-3 weeks.
  • Sputum Production: Often clear or white; yellow or green sputum does not necessarily indicate bacterial infection.
  • Chest Discomfort: A feeling of tightness or pain in the chest, usually due to prolonged coughing.
  • Wheezing: Can occur due to bronchospasm, particularly in children with underlying reactive airway disease.
  • Mild Dyspnea: Shortness of breath, especially if the cough is severe.
  • Low-Grade Fever and Malaise: Less common in viral cases; high fever may suggest pneumonia or a severe systemic infection.

Cutoff Age:

• Children and Adolescents: While acute bronchitis can occur in all age groups, it is more commonly diagnosed in older children and adolescents rather than infants.
• Infants: In children under 2 years of age, bronchiolitis is more commonly diagnosed than acute bronchitis due to the involvement of smaller airways.

Physical Examination:

• Positive Findings:
  • Wheezing or Rhonchi: Heard on auscultation, often clears with coughing.
  • Signs of Upper Respiratory Infection: Such as nasal congestion, rhinorrhea, and pharyngitis.
• Negative Findings:
  • Absence of Systemic Signs of Severe Infection: No high fever, tachypnea, or hypoxia, which might suggest pneumonia or other serious conditions.

Diagnostic Approach:

• Clinical Diagnosis: Acute bronchitis is primarily diagnosed based on clinical presentation and history.
• Differential Diagnosis: Must rule out other respiratory conditions like pneumonia, asthma, foreign body aspiration, and COPD exacerbation, especially in patients with a history of reactive airway disease or other comorbidities.
• Investigations:
  • Chest X-ray: Generally not indicated unless there are signs or symptoms suggestive of pneumonia (e.g., high fever, hypoxia, abnormal breath sounds that do not clear with cough).
  • Spirometry: Useful in cases where underlying asthma or COPD is suspected.

Management:

• Supportive Treatment:
  • Hydration: Encouraging fluid intake to help thin mucus.
  • Antipyretics/Analgesics: Acetaminophen or ibuprofen for fever, malaise, and chest discomfort.
  • Cough Suppressants: Not routinely recommended, but can be considered if the cough is severely affecting sleep or causing significant discomfort.
  • Inhaled Bronchodilators: For patients with wheezing or bronchospasm, especially if there is a history of reactive airway disease.
• Antibiotics: Not recommended in most cases since acute bronchitis is usually viral. Consider antibiotics only if there is a high suspicion of bacterial infection, such as in children with chronic lung disease or those who do not improve.

Patient Education:

• Educate the patient and caregivers about the typical course of the illness and emphasize that antibiotics are not necessary for most cases.
• Discuss the importance of smoking cessation if applicable and minimizing exposure to environmental irritants.

Prognosis: Most children recover fully with supportive care. Symptoms typically resolve within a few weeks. Persistent cough may require reevaluation for other underlying conditions, such as asthma or gastroesophageal reflux disease (GERD).

When to Seek Further Medical Attention:

• Symptoms persisting for more than 3 weeks.
• Worsening respiratory symptoms, high fever, chest pain, or hemoptysis.
• In patients with pre-existing lung conditions or immunocompromised states, closer monitoring and follow-up may be needed.

---

Bronchiolitis:

Definition: Bronchiolitis is a viral lower respiratory tract infection that affects the small airways (bronchioles) and is predominantly seen in infants and young children under 2 years of age. It is characterized by inflammation, edema, and necrosis of epithelial cells lining the small airways, leading to airway obstruction.

Etiology and Risk Factors:

• Common Causes:
  • Respiratory Syncytial Virus (RSV): The most common cause of bronchiolitis, especially in infants and young children.
  • Other Viruses: Rhinovirus, influenza virus, parainfluenza virus, and adenovirus can also cause bronchiolitis.
• Risk Factors:
  • Age: Infants under 2 years of age, especially those between 2 to 6 months, are at the highest risk.
  • Prematurity: Preterm infants are more susceptible due to underdeveloped lungs and immune systems.
  • Environmental Factors: Exposure to tobacco smoke, crowded living conditions, and daycare attendance increase the risk.
  • Lack of Breastfeeding: Breastfeeding provides protective antibodies that reduce the risk of respiratory infections.
  • Underlying Health Conditions: Chronic lung disease, congenital heart disease, or immunodeficiency.

Pathophysiology: The viral infection leads to necrosis of the bronchiolar epithelium, inflammation, and increased mucus production. This causes obstruction of the small airways, resulting in air trapping and atelectasis. The obstruction is often worsened by the small diameter of the bronchioles in infants, leading to significant respiratory distress.

Clinical Presentation:

• Initial Symptoms: Start with mild upper respiratory symptoms such as a runny nose, mild cough, and low-grade fever.
• Progression: After 2-3 days, symptoms can worsen, leading to:
  • Tachypnea: Rapid breathing as the body compensates for hypoxia and increased work of breathing.
  • Wheezing: Caused by airflow limitation in the bronchioles.
  • Retractions: Visible sinking of the chest wall during inhalation due to increased respiratory effort.
  • Cyanosis: Bluish discoloration of the skin, especially around the lips and fingertips, indicating hypoxia.
  • Apnea: Particularly in very young infants, brief episodes of stopped breathing.
  • Decreased Feeding and Irritability: Due to respiratory distress and fatigue.

Cutoff Age:

• Infants and Young Children: Primarily affects those under 2 years of age, with the highest incidence in infants aged 2 to 6 months.
• Older Children and Adults: Rare in older children and adults; when similar symptoms occur in these age groups, they are usually diagnosed as asthma or viral-induced wheezing.

Physical Examination:

• Positive Findings:
  • Tachypnea with Nasal Flaring: A sign of respiratory distress.
  • Intercostal and Subcostal Retractions: Indicate increased work of breathing.
  • Wheezing and Crackles: Heard on auscultation due to obstruction and mucus plugging.
  • Prolonged Expiratory Phase: Due to airway obstruction.
  • Hypoxia: Low oxygen saturation, often <90% in severe cases.
• Negative Findings:
  • Absence of High Fever: A high fever may suggest a secondary bacterial infection.

Diagnostic Evaluation:

• Diagnosis: Primarily clinical based on history and physical examination.
• Investigations:
  • Pulse Oximetry: To assess oxygen saturation levels and monitor hypoxia.
  • Chest X-ray: Not routinely required but may be done in severe cases to rule out other conditions like pneumonia. Typical findings include hyperinflation, peribronchial thickening, and patchy atelectasis.
  • Nasopharyngeal Swab: PCR testing for RSV and other viruses can confirm the viral etiology but is not usually necessary for routine management.

Management:

• Supportive Treatment:
  • Oxygen Therapy: To maintain oxygen saturation above 90%. Administered via nasal cannula, face mask, or high-flow nasal cannula depending on the severity.
  • Hydration: Ensuring adequate fluid intake, orally or via intravenous (IV) fluids if the child is unable to maintain adequate oral intake due to respiratory distress.
  • Nasal Suctioning: To clear nasal secretions, especially before feeding to improve intake and reduce respiratory effort.
  • Bronchodilators: Not routinely recommended as they have not shown consistent benefit. A trial may be considered in cases with a history of reactive airway disease, with close monitoring for improvement.
  • Steroids and Antibiotics: Not recommended unless there is a suspicion of a secondary bacterial infection or an underlying condition such as asthma that may benefit from steroids.
• Hospitalization: Indicated for infants and young children with severe symptoms, significant respiratory distress, apnea, or inability to maintain adequate hydration due to respiratory compromise.

Prevention:

• Hand Hygiene: Frequent handwashing to reduce the spread of respiratory viruses.
• Avoiding Smoke Exposure: Reducing exposure to tobacco smoke and other respiratory irritants.
• Palivizumab: A monoclonal antibody given prophylactically to high-risk infants (e.g., those born prematurely or with congenital heart disease) during RSV season to prevent severe RSV infection.

Complications:

• Severe Dehydration: Due to increased respiratory rate and decreased oral intake.
• Respiratory Failure: Requiring mechanical ventilation in severe cases.
• Apnea: Particularly in very young infants, which can be life-threatening.
• Secondary Bacterial Infections: Such as pneumonia, although less common.

Prognosis: The prognosis for bronchiolitis is generally good, with most children recovering fully without long-term sequelae. However, some children, particularly those with severe or recurrent bronchiolitis, may develop recurrent wheezing or asthma later in life.

Medication Dosages for Management

For acute bronchitis in pediatric patients:

• Cough Suppressants (for severe cough affecting sleep): Dextromethorphan 0.5 mg/kg per dose every 4-6 hours (maximum: 10 mg per dose, 60 mg/day).
• Inhaled Bronchodilators (for wheezing): Albuterol 0.15 mg/kg (minimum 2.5 mg, maximum 5 mg) via nebulizer every 4-6 hours as needed.

For bronchiolitis in pediatric patients:

• Oxygen Therapy: Administer to maintain oxygen saturation >90%. Use nasal cannula or face mask as appropriate.
• Hydration: Oral fluids or IV normal saline if unable to maintain oral intake due to respiratory distress or dehydration.
• Nasal Suctioning: Frequent suctioning using a bulb syringe or suction catheter, especially before feeds, to clear secretions and reduce work of breathing.

If antibiotics are indicated (e.g., for suspected secondary bacterial superinfection):

• Amoxicillin-Clavulanate: Amoxicillin 45-90 mg/kg/day in divided doses every 12 hours.
• Azithromycin: 10 mg/kg on day 1 (maximum 500 mg), then 5 mg/kg on days 2-5 (maximum 250 mg daily).

This comprehensive overview for pediatric residents includes detailed etiology, pathophysiology, clinical presentation, management strategies, and specific age considerations for both acute bronchitis and bronchiolitis. Emphasis is placed on evidence-based management and the judicious use of medications, including when to use antibiotics, to guide clinical practice effectively.